To further predict the potential role in AD regulated by NAP1L5, GSEA results from GSE37263 datasets showed that neurodegenerative diseases, the crucial diseases of the nervous system involving Parkinson’s disease and AD, were strongly correlated with the expression level of NAP1L5 (Figure 1C). This evidence concerns the gene NAP1L5 and Alzheimer disease.